Literature DB >> 27125649

HOXB13 expression in metastatic prostate cancer.

Valeria Barresi1, Antonio Ieni2, Luca Reggiani Bonetti3, Giovanni Tuccari2.   

Abstract

Entities:  

Year:  2016        PMID： 27125649     DOI： 10.1007/s00428-016-1946-5

Source DB:  PubMed          Journal:  Virchows Arch        ISSN： 0945-6317            Impact factor:   4.064


× No keyword cloud information.
  4 in total

1.  Do HOXB13 and P63 have a role in differentiating poorly differentiated prostatic carcinoma from urothelial high-grade carcinoma?

Authors:  Hanan AlSaeid Alshenawy; Eman Saied
Journal:  APMIS       Date:  2015-07-22       Impact factor: 3.205

2.  HOXB13 as an immunohistochemical marker of prostatic origin in metastatic tumors.

Authors:  Valeria Barresi; Antonio Ieni; Roberta Cardia; Luana Licata; Enrica Vitarelli; Luca Reggiani Bonetti; Giovanni Tuccari
Journal:  APMIS       Date:  2015-11-20       Impact factor: 3.205

3.  HOXB13 protein expression in metastatic lesions is a promising marker for prostate origin.

Authors:  Justine Varinot; Adéline Furudoï; Sarah Drouin; Véronique Phe; Raphaele Renard Penna; Morgan Roupret; Marc-Olivier Bitker; Olivier Cussenot; Eva Compérat
Journal:  Virchows Arch       Date:  2016-03-01       Impact factor: 4.064

4.  HOXB13 is a sensitive and specific marker of prostate cells, useful in distinguishing between carcinomas of prostatic and urothelial origin.

Authors:  Justine Varinot; Olivier Cussenot; Morgan Roupret; Pierre Conort; Marc-Olivier Bitker; Emmanuel Chartier-Kastler; Liang Cheng; Eva Compérat
Journal:  Virchows Arch       Date:  2013-10-22       Impact factor: 4.064
  4 in total
  1 in total

1.  The Homeobox gene, HOXB13, Regulates a Mitotic Protein-Kinase Interaction Network in Metastatic Prostate Cancers.

Authors:  Jiqiang Yao; Yunyun Chen; Duy T Nguyen; Zachary J Thompson; Alexey M Eroshkin; Niveditha Nerlakanti; Ami K Patel; Neha Agarwal; Jamie K Teer; Jasreman Dhillon; Domenico Coppola; Jingsong Zhang; Ranjan Perera; Youngchul Kim; Kiran Mahajan
Journal:  Sci Rep       Date:  2019-07-04       Impact factor: 4.379
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.